Phacilitate Leaders World

Sponsors & Exhibitors

FUJIFILM Diosynth Biotechnologies

FUJIFILM Diosynth Biotechnologies is an industry leading Biologics Contract Development and Manufacturing Organisation for the biopharmaceutical industry with over 30 years of experience.  In December 2014 we expanded our vaccines capabilities with the acquisition of Kalon Biotherapeutics LLC, based in College Station, TX, USA. 

This facility includes a fully operational flexible, mobile clean room operation with up to BSL-2 containment capability, with additional facilities under construction.  These complement our comprehensive development and manufacturing capabilities in Billingham, UK, and Research Triangle Park, NC, and our extensive experience in the development and manufacture of recombinant proteins, vaccines, monoclonal antibodies, expressed in a wide range of systems.  We offer a comprehensive list of services from cell line and strain development, including our proprietary pAVEway™ microbial and Apollo™ mammalian systems, to process and analytical development, clinical and commercial manufacturing. 

Visit Website
View all Sponsors & Exhibitors
Loading
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK